![](https://images.aatbio.com/dataset/ic50/neurotrophic-tyrosine-kinase-receptor-type-2_1d5eba4b4bb57896dda18b1604bab021.svg) | Staurosporine | IC50 | 0.96 [1], 1.0 [2], 4.5 [3] |
![](https://images.aatbio.com/dataset/ic50/neurotrophic-tyrosine-kinase-receptor-type-2_c77eb69f87d46b4d00314a6bfb851cf8.svg) | Crizotinib | IC50 | 2.0 [1], 399.0 [2] |
![](https://images.aatbio.com/dataset/ic50/neurotrophic-tyrosine-kinase-receptor-type-2_26575b04a0a4cc9959845db9b7bd7b68.svg) | Purvalanol B | IC50 | 11.0 [1], 1300.0 [2] |
![](https://images.aatbio.com/dataset/ic50/neurotrophic-tyrosine-kinase-receptor-type-2_2dabc63bb17d7aa9a6e1efcaa499f8ea.svg) | Lorlatinib | Ki | 23.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurotrophic-tyrosine-kinase-receptor-type-2_c38cbdee4404993837adfc282c860ec1.svg) | Nvp-tae 684 | IC50 | 2018.0 [1], 422000.0 [2] |
![](https://images.aatbio.com/dataset/ic50/neurotrophic-tyrosine-kinase-receptor-type-2_2adbc4a307d22bed17e0f710542542e9.svg) | Entrectinib | IC50 | 3.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurotrophic-tyrosine-kinase-receptor-type-2_b6faf72dfa81ac6f5cbbee7518dcb7f6.svg) | 4-[6-(Benzylamino)imidazo[1,2-B]pyridazin-3-Yl]benzonitrile | IC50 | 83.0 [1], 270.0 [2] |
![](https://images.aatbio.com/dataset/ic50/neurotrophic-tyrosine-kinase-receptor-type-2_eac8fdfdf0a2ec660a53a165ee7ba8d9.svg) | 1-[[3-Methoxy-4-[(4-methoxyphenyl)methoxy]phenyl]methyl]-5-(1-methylpyrazol-4-yl)benzimidazol-2-amine | IC50 | 0.3 [1], 0.5 [2] |
![](https://images.aatbio.com/dataset/ic50/neurotrophic-tyrosine-kinase-receptor-type-2_4d123edd3ad9e2be6e95fa15409f9464.svg) | Staurosporine HCl | IC50 | 1.18 [1] |
![](https://images.aatbio.com/dataset/ic50/neurotrophic-tyrosine-kinase-receptor-type-2_b5f9e60dc2b2b7e76e07307c1d8f7888.svg) | Bosutinib | IC50 | 27.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurotrophic-tyrosine-kinase-receptor-type-2_295456cbf7462dfb1eaccb88d6610904.svg) | Ceritinib | IC50 | 1829.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurotrophic-tyrosine-kinase-receptor-type-2_0a83b01cf93719a90ccaeda771089c43.svg) | Doramapimod | IC50 | 50.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurotrophic-tyrosine-kinase-receptor-type-2_34a499a7d2761583e49292b562c19214.svg) | Larotrectinib | IC50 | 24.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurotrophic-tyrosine-kinase-receptor-type-2_7e037c210cad9a24b0c9ce116fb5b97c.svg) | CID 53469448 | IC50 | 2962.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurotrophic-tyrosine-kinase-receptor-type-2_e7ecb06887875f4d78baf892d82c33a5.svg) | Bms-777607 | IC50 | 190.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurotrophic-tyrosine-kinase-receptor-type-2_ad2e213c6bc5eb972596bba5a265d460.svg) | 1-(3-Chlorophenyl)-3-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)ethyl]-1,3-Thiazol-2-Yl}urea | IC50 | 5.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurotrophic-tyrosine-kinase-receptor-type-2_4e8b5202a71aafe003ab207cc4576058.svg) | 3-(1H-Indol-5-yl)-5-(4-((4-methylpiperazin-1-yl)methyl)phenyl)-1H-pyrrolo[2,3-b]pyridine | IC50 | 217.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurotrophic-tyrosine-kinase-receptor-type-2_84fae1800055ebf670b925911d10e379.svg) | CFI-400945 (free base) | IC50 | 9.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurotrophic-tyrosine-kinase-receptor-type-2_179888a64edb35ddee0be2a16e245b3a.svg) | MK-2461 | IC50 | 61.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurotrophic-tyrosine-kinase-receptor-type-2_478f8c74275fce83224a96edad0f0b1f.svg) | JNK Inhibitor VIII | Ki | 4500.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurotrophic-tyrosine-kinase-receptor-type-2_905a24aca444feb76c904879d21d8ea8.svg) | AZ-23 | IC50 | 6.8 [1] |
![](https://images.aatbio.com/dataset/ic50/neurotrophic-tyrosine-kinase-receptor-type-2_f48bc7cff8211f038f697b8a001dddb8.svg) | Unii-76pnd635L1 | IC50 | 4.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurotrophic-tyrosine-kinase-receptor-type-2_b09f9bb157cd7a5fddf59804ac65a085.svg) | Altiratinib | IC50 | 4.6 [1] |
![](https://images.aatbio.com/dataset/ic50/neurotrophic-tyrosine-kinase-receptor-type-2_15a4bcfb2ea319b026c020006e2b004c.svg) | Cep-11981 | IC50 | 5.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurotrophic-tyrosine-kinase-receptor-type-2_42f33b1083071f5eadfc0481de54c5bc.svg) | Dual DDR1 and DDR2 inhibitor 5n | IC50 | 40.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurotrophic-tyrosine-kinase-receptor-type-2_43d297b7b1a93032a159397e6d902cf2.svg) | CID 59397065 | IC50 | 12.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurotrophic-tyrosine-kinase-receptor-type-2_c4efceda17e53de30b363a8b6106fac2.svg) | N-(4-Amino-5-cyano-6-ethoxypyridin-2-yl)acetamide | Ki | 4500.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurotrophic-tyrosine-kinase-receptor-type-2_a8db7d1164098dbe83e74bfac894881a.svg) | 4-Amino-5-chloro-6-ethoxy-pyridine-2-carboxylic acid 4-methanesulfonyl-benzylamide | Ki | 4500.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurotrophic-tyrosine-kinase-receptor-type-2_99d590530c99b53efc4907213bcd8b23.svg) | 7-Chloro-3-oxo-8-(1,3-thiazol-5-ylmethylamino)-11,16-dioxa-2,4,19,21-tetrazatricyclo[15.3.1.05,10]henicosa-1(20),5,7,9,17(21),18-hexaene-18-carbonitrile | Ki | 4536.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurotrophic-tyrosine-kinase-receptor-type-2_21aa752395444707db3d7c65ae53dc35.svg) | 1-({4-[(3,4-Dichlorophenyl)methoxy]phenyl}methyl)azetidine-3-carboxylic acid | IC50 | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurotrophic-tyrosine-kinase-receptor-type-2_9b77e0d646f6d1ac3a7ddedb939fdf94.svg) | 2-[[1-Cyclopentyl-5-[1-(Oxetan-3-Yl)piperidin-4-Yl]pyrazol-3-Yl]amino]pyridine-4-Carbonitrile | IC50 | 1190000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurotrophic-tyrosine-kinase-receptor-type-2_1a1e22301f160f58a6a5333d13bf81fe.svg) | 4-({5-Bromo-4-[(4-methoxyphenyl)amino]pyrimidin-2-yl}amino)benzoic acid | IC50 | 646.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurotrophic-tyrosine-kinase-receptor-type-2_0731e513dda8b4631f904dc8f0082e8c.svg) | 7-Chloro-8-(3-hydroxypropoxy)-3-oxo-11,17-dioxa-2,4,20,22-tetrazatricyclo[16.3.1.05,10]docosa-1(21),5,7,9,18(22),19-hexaene-19-carbonitrile | Ki | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurotrophic-tyrosine-kinase-receptor-type-2_1fe60e6d13674f8cf1dfc82fac3410b2.svg) | 7-Chloro-8-(3-hydroxypropyl)-3-oxo-11,17-dioxa-2,4,20,22-tetrazatricyclo[16.3.1.05,10]docosa-1(21),5(10),6,8,18(22),19-hexaene-19-carbonitrile | Ki | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurotrophic-tyrosine-kinase-receptor-type-2_029f5b4cad89a2c59efa869fd9853874.svg) | N-(7-Chloro-19-cyano-3-oxo-11,17-dioxa-2,4,20,22-tetrazatricyclo[16.3.1.05,10]docosa-1(21),5,7,9,18(22),19-hexaen-8-yl)methanesulfonamide | Ki | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurotrophic-tyrosine-kinase-receptor-type-2_c2aa7e0fb640ea7529d7330460976868.svg) | N-(4-Amino-5-cyano-6-ethoxypyridin-2-yl)-2-(2,5-dimethoxy-4-methylsulfonylphenyl)acetamide | Ki | 4500.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurotrophic-tyrosine-kinase-receptor-type-2_98598461b658b3f77425e67c797f8e2d.svg) | N-(4-Amino-5-chloro-6-ethoxypyridin-2-yl)-2-(4-methanesulfonyl-2,5-dimethoxyphenyl)acetamide | Ki | 4500.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurotrophic-tyrosine-kinase-receptor-type-2_a3bd9a5a28d4f4d2890ccf5cdf08d883.svg) | N-(4-Amino-5-cyano-6-isopropoxypyridin-2-yl)-2-(4-methanesulfonyl-2,5-dimethoxyphenyl)acetamide | Ki | 4500.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurotrophic-tyrosine-kinase-receptor-type-2_cde4e83180955e4849d8daba0837480d.svg) | N-(4-Amino-5-cyano-6-phenylpyridin-2-yl)acetamide | Ki | 4500.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurotrophic-tyrosine-kinase-receptor-type-2_f046ae8812a77e5cb35fd8b53bebf05d.svg) | Ripk1-IN-7 | IC50 | 8.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurotrophic-tyrosine-kinase-receptor-type-2_b076cdaba7bb8b7d9a4e8120c86a34a8.svg) | N-Propyl-4-({4-[(2,2,2-trifluoroethyl)amino]-1H-pyrrolo[2,3-d]pyrimidin-2-yl}amino)benzamide | IC50 | 126.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurotrophic-tyrosine-kinase-receptor-type-2_b80728998e0b173ed97842a79c1db051.svg) | 5-(2-Aminoethyl)-7-(7-(benzo[b]thiophen-2-yl)-1H-indazol-5-yl)-5H-pyrrolo[3,2-d]pyrimidin-2-amine | IC50 | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurotrophic-tyrosine-kinase-receptor-type-2_d177c352a8a90316beccdf76166341e8.svg) | N-[3-[5-[2-(3-Morpholin-4-ylanilino)pyrimidin-4-yl]imidazo[2,1-b][1,3]thiazol-6-yl]phenyl]-2-phenylacetamide | IC50 | 1000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurotrophic-tyrosine-kinase-receptor-type-2_dcf1cd66de7c1bdcab62160a0a9db4e0.svg) | N-[5-Amino-1-[(4-methoxyphenyl)methyl]pyrazol-4-yl]-5-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]-2-methylbenzamide | IC50 | 1.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurotrophic-tyrosine-kinase-receptor-type-2_400786f64062ecb5f10a9d3b11455207.svg) | 1-[5-Tert-butyl-3-[4-[2-(dimethylamino)ethyl]-5-oxo-1,4-diazepane-1-carbonyl]thiophen-2-yl]-3-(2,3-dichlorophenyl)urea | IC50 | 8700.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurotrophic-tyrosine-kinase-receptor-type-2_3e5e956fd3311d2f1725fa72559e89d1.svg) | CID 59627005 | IC50 | 100.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurotrophic-tyrosine-kinase-receptor-type-2_51153882d3ab9f3566d96aeaf5c3eeab.svg) | 6-(2,4-Difluorophenyl)sulfonyl-2-(1H-indol-5-ylamino)-8-methylpyrido[2,3-d]pyrimidin-7-one | IC50 | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurotrophic-tyrosine-kinase-receptor-type-2_59bc3b4f403ec2d9c864ecd3d0a58982.svg) | N-(5-Cyclopropyl-2-phenylpyrazol-3-yl)-2-[4-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]triazol-1-yl]acetamide | IC50 | 132.2 [1] |
![](https://images.aatbio.com/dataset/ic50/neurotrophic-tyrosine-kinase-receptor-type-2_024edde474cd699e50f6071a083374a4.svg) | (4S,5R,6Z,9S,10S,12E)-9,10,18-Trihydroxy-4,5-dimethyl-16-(methylamino)-3-oxabicyclo[12.4.0]octadeca-1(14),6,12,15,17-pentaene-2,8-dione | IC50 | 26.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurotrophic-tyrosine-kinase-receptor-type-2_a5d9779a50d95f4c3e71c26f9d957915.svg) | 3-(4-Methylimidazol-1-yl)-N-[3-[[(3Z)-2-oxo-3-(1H-pyrrol-2-ylmethylidene)-1H-indol-6-yl]amino]phenyl]-5-(trifluoromethyl)benzamide | IC50 | 54.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurotrophic-tyrosine-kinase-receptor-type-2_c5a9430d09f54ebb1744008c07c7976d.svg) | 1-[(3S,4R)-4-(3,4-Difluorophenyl)-1-(2-methoxyethyl)pyrrolidin-3-yl]-3-(5-ethoxy-4-methyl-2-phenylpyrazol-3-yl)urea | IC50 | 1303.7 [1] |
![](https://images.aatbio.com/dataset/ic50/neurotrophic-tyrosine-kinase-receptor-type-2_b0e61fcd49efb38a39f86beba08ce995.svg) | Trk-IN-4 | IC50 | 2.6 [1] |
![](https://images.aatbio.com/dataset/ic50/neurotrophic-tyrosine-kinase-receptor-type-2_c9712ca4c83977905731167ece3950f0.svg) | 5-(1-Methyl-1H-imidazol-4-yl)-2-[(1-{[4-(trifluoromethoxy)phenyl]acetyl}piperidin-4-yl)oxy]benzamide | IC50 | 6.1 [1] |
![](https://images.aatbio.com/dataset/ic50/neurotrophic-tyrosine-kinase-receptor-type-2_4195f421ef2f04adeb7935c126157eb2.svg) | 2-[(3R,4S)-3-Fluoro-1-[2-[4-(trifluoromethoxy)phenyl]acetyl]piperidin-4-yl]oxy-4-(2-hydroxy-2-methylpropoxy)benzamide | IC50 | 15.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurotrophic-tyrosine-kinase-receptor-type-2_8bd091eda23bec3351e3234f1a074c2b.svg) | 6-Amino-5-[(3S)-4,4-difluoro-1-[2-[4-(trifluoromethoxy)phenyl]acetyl]pyrrolidin-3-yl]oxy-N-methylpyridine-3-carboxamide | IC50 | 6.2 [1] |
![](https://images.aatbio.com/dataset/ic50/neurotrophic-tyrosine-kinase-receptor-type-2_5db4301280d4f501406f122defb760d5.svg) | 3-[6-(Benzylamino)imidazo[1,2-b]pyridazin-3-yl]benzonitrile | IC50 | 200.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurotrophic-tyrosine-kinase-receptor-type-2_69f89b3a45eb9613f1d2506f55603805.svg) | 4-[6-[(2-Methoxyphenyl)methylamino]imidazo[1,2-b]pyridazin-3-yl]benzonitrile | IC50 | 120.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurotrophic-tyrosine-kinase-receptor-type-2_d90608aca766c82eb98102da821d92af.svg) | [4-[6-[(3-Fluorophenyl)methylamino]imidazo[1,2-b]pyridazin-3-yl]phenyl]methanol | IC50 | 27.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurotrophic-tyrosine-kinase-receptor-type-2_66668e4cd924891d54651b994776b227.svg) | N-[4-[6-[(3-Fluorophenyl)methylamino]imidazo[1,2-b]pyridazin-3-yl]phenyl]oxane-4-carboxamide | IC50 | 7.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurotrophic-tyrosine-kinase-receptor-type-2_ecc9b773026eac1d9f254312a4e6dc94.svg) | 4-[6-[Benzyl(methyl)amino]imidazo[1,2-b]pyridazin-3-yl]benzonitrile | IC50 | 130.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurotrophic-tyrosine-kinase-receptor-type-2_5d7901f03aa52a959c119b7fc87d0b0c.svg) | 6-[(2r)-2-(3-Fluorophenyl)pyrrolidin-1-Yl]-3-(Pyridin-2-Yl)imidazo[1,2-B]pyridazine | IC50 | 1.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurotrophic-tyrosine-kinase-receptor-type-2_07f245678e6fcc2d52455f8c1a6544d0.svg) | 2-[4-[4-[6-[(2R)-2-(3-Fluorophenyl)pyrrolidin-1-yl]imidazo[1,2-b]pyridazin-3-yl]pyridin-2-yl]piperazin-1-yl]acetic acid | IC50 | 1.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurotrophic-tyrosine-kinase-receptor-type-2_cadcfe40c75731fb4d071e8664de359c.svg) | 1-[4-[6-[(2R)-2-(3-Fluorophenyl)pyrrolidin-1-yl]imidazo[1,2-b]pyridazin-3-yl]pyridin-2-yl]piperidin-4-ol | IC50 | 4.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurotrophic-tyrosine-kinase-receptor-type-2_dc5ff7b87d06ec962585df9a614f5950.svg) | 6-[4-[(5-Tert-butyl-1,2-oxazol-3-yl)carbamoylamino]phenyl]-N-[3-(dimethylamino)propyl]imidazo[2,1-b][1,3]thiazole-3-carboxamide | IC50 | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurotrophic-tyrosine-kinase-receptor-type-2_a6cc6a00a743f0587c67cce3f5c9a041.svg) | 5-(1-Methylpyrazol-4-yl)-2-[1-[2-[4-(trifluoromethoxy)phenyl]acetyl]piperidin-4-yl]oxybenzamide | IC50 | 4.2 [1] |
![](https://images.aatbio.com/dataset/ic50/neurotrophic-tyrosine-kinase-receptor-type-2_0b43927816ebbc9be13e6e44e4f9f2e1.svg) | 5,5-Dimethyl-8-[[4-(2,2,2-trifluoroethylamino)furo[3,2-d]pyrimidin-2-yl]amino]-1H-4,1-benzoxazepin-2-one | IC50 | 379.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurotrophic-tyrosine-kinase-receptor-type-2_bc06f7a8157019bf41c79afd90bf15b9.svg) | 6-(1-Methylpyrazol-4-yl)-3-[1-[2-[4-(trifluoromethoxy)phenyl]acetyl]piperidin-4-yl]oxypyridine-2-carboxamide | IC50 | 6.6 [1] |
![](https://images.aatbio.com/dataset/ic50/neurotrophic-tyrosine-kinase-receptor-type-2_48b8d3d44975279314c01d724a042876.svg) | 6-(1-Methylpyrazol-4-yl)-3-[(3R)-1-[2-[4-(trifluoromethoxy)phenyl]acetyl]pyrrolidin-3-yl]oxypyridine-2-carboxamide | IC50 | 2.7 [1] |
![](https://images.aatbio.com/dataset/ic50/neurotrophic-tyrosine-kinase-receptor-type-2_a9dcdd07060aafae23988532f79fe544.svg) | 6-(1-Methylpyrazol-4-yl)-3-[(3S)-1-[2-[4-(trifluoromethoxy)phenyl]acetyl]pyrrolidin-3-yl]oxypyridine-2-carboxamide | IC50 | 900.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurotrophic-tyrosine-kinase-receptor-type-2_d6ce109df320741cd263b46e9fcab09c.svg) | 4-[2-Carbamoyl-4-(1-methylpyrazol-4-yl)phenoxy]-N-[4-(trifluoromethoxy)phenyl]piperidine-1-carboxamide | IC50 | 29.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurotrophic-tyrosine-kinase-receptor-type-2_465e90a09f0b19aa824fdc7d1d6fd633.svg) | 7-Cyclohexyl-N-[4-(4-methylpiperazin-1-yl)phenyl]pyrrolo[2,3-d]pyrimidin-2-amine | IC50 | 160.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurotrophic-tyrosine-kinase-receptor-type-2_984f1d19dd4f7aff4c8096322cf2c2cd.svg) | 4-(2-Chloro-4-fluorophenyl)-8-(2,6-dichlorophenyl)-7-oxido-1,7-naphthyridin-7-ium | IC50 | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurotrophic-tyrosine-kinase-receptor-type-2_d5c2c6b25eb5b578a036483d01253ca9.svg) | 4-[6-(3-Fluoro-benzylamino)-imidazo[1,2-b]pyridazin-3-yl]-benzenesulfonamide | IC50 | 13.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurotrophic-tyrosine-kinase-receptor-type-2_52f27d9c8be93f1e232baf690563858c.svg) | 4-[6-[(2R)-2-(3-Fluorophenyl)pyrrolidin-1-yl]imidazo[1,2-b]pyridazin-3-yl]benzonitrile | IC50 | 11.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurotrophic-tyrosine-kinase-receptor-type-2_321c67939d5479293a2d25aaa0259cfe.svg) | CID 24971342 | IC50 | 1100.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurotrophic-tyrosine-kinase-receptor-type-2_00d7d011e00ff0302b02ebe8496e7d5d.svg) | 4-((3-(4-Cyclohexylpiperazin-1-yl)-6-oxo-6H-anthra[1,9-cd]isoxazol-5-yl)amino)benzoic acid | IC50 | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurotrophic-tyrosine-kinase-receptor-type-2_051aa53aabdb0251648b5e1b7c3a624d.svg) | 4-[6-[2-(3-Fluorophenyl)piperidin-1-yl]imidazo[1,2-b]pyridazin-3-yl]benzonitrile | IC50 | 50.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurotrophic-tyrosine-kinase-receptor-type-2_cbec3dfc801f6c0fa47612cd4b4b7881.svg) | 4-[6-[3-(3-Fluorophenyl)morpholin-4-yl]imidazo[1,2-b]pyridazin-3-yl]benzonitrile | IC50 | 47.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurotrophic-tyrosine-kinase-receptor-type-2_c469e4978aa86efa1ed141e8ebab0509.svg) | 4-[6-[2-(3-Fluorophenyl)pyrrolidin-1-yl]imidazo[1,2-b]pyridazin-3-yl]benzonitrile | IC50 | 29.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurotrophic-tyrosine-kinase-receptor-type-2_122eb4aee902783528d1fb649522f3f0.svg) | 4-[6-[(2S)-2-(3-Fluorophenyl)pyrrolidin-1-yl]imidazo[1,2-b]pyridazin-3-yl]benzonitrile | IC50 | 1970.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurotrophic-tyrosine-kinase-receptor-type-2_d34c75fb9050e2e16397466a936a127d.svg) | 29-(Dimethylamino)-4,14,24,30-tetrazaheptacyclo[26.2.2.14,11.117,24.05,10.012,16.018,23]tetratriaconta-1(30),5,7,9,11(34),12(16),17(33),18,20,22,28,31-dodecaene-13,15-dione | IC50 | 3000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurotrophic-tyrosine-kinase-receptor-type-2_a840767d7ddb2c27c40164419a996160.svg) | Infigratinib phosphate | IC50 | 3139.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurotrophic-tyrosine-kinase-receptor-type-2_bb79925ac133b93ba04556e4a1ea231c.svg) | 5-Amino-N-[3-(2,5-dichlorophenyl)-1-methylpyrazol-4-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide | IC50 | 5380.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurotrophic-tyrosine-kinase-receptor-type-2_c7436272985b8e0e7b8f73be90c02549.svg) | 1-[6-[6-[(2R)-2-(3-Fluorophenyl)pyrrolidin-1-yl]imidazo[1,2-b]pyridazin-3-yl]pyridin-2-yl]piperidin-4-ol | IC50 | 4.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurotrophic-tyrosine-kinase-receptor-type-2_a8336736adadda2748af56218b3c6c3b.svg) | N-[3-[[(3Z)-3-[(4-Cyano-1H-pyrrol-2-yl)methylidene]-2-oxo-1H-indol-6-yl]amino]phenyl]-3-(4-methylpiperazin-1-yl)-5-(trifluoromethyl)benzamide | IC50 | 27.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurotrophic-tyrosine-kinase-receptor-type-2_f05f09f854f7881383e9fb4e07382994.svg) | N-[3-(Dimethylamino)propyl]-2,4-dimethyl-5-[(Z)-[6-[3-[[3-(4-methylpiperazin-1-yl)-5-(trifluoromethyl)benzoyl]amino]anilino]-2-oxo-1H-indol-3-ylidene]methyl]-1H-pyrrole-3-carboxamide | IC50 | 15.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurotrophic-tyrosine-kinase-receptor-type-2_7e4bbdf24e5f2dcfc1e36a539666b674.svg) | 3-(4-Methylpiperazin-1-yl)-N-[3-[[(3Z)-2-oxo-3-(1H-pyrrol-2-ylmethylidene)-1H-indol-6-yl]amino]phenyl]-5-(trifluoromethyl)benzamide | IC50 | 7.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurotrophic-tyrosine-kinase-receptor-type-2_8434031bc5134e03601e5f4c9b94ff43.svg) | 3-(4-Hydroxypiperidin-1-yl)-N-[3-[[(3Z)-2-oxo-3-(1H-pyrrol-2-ylmethylidene)-1H-indol-6-yl]amino]phenyl]-5-(trifluoromethyl)benzamide | IC50 | 60.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurotrophic-tyrosine-kinase-receptor-type-2_4e600498eb14c9b2f134bb96d54e62e9.svg) | 3-[4-(2-Hydroxyethyl)piperazin-1-yl]-N-[3-[[(3Z)-2-oxo-3-(1H-pyrrol-2-ylmethylidene)-1H-indol-6-yl]amino]phenyl]-5-(trifluoromethyl)benzamide | IC50 | 35.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurotrophic-tyrosine-kinase-receptor-type-2_f980e35cc5a89e33324ed62d29bf7e45.svg) | 2-N-(1H-Indazol-6-yl)-4-N-(2,2,2-trifluoroethyl)furo[3,2-d]pyrimidine-2,4-diamine | IC50 | 5240.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurotrophic-tyrosine-kinase-receptor-type-2_ea7d68d5631badf4d76195468cfe148a.svg) | N~4~-Cyclopropyl-N~2~-(3-Methyl-1h-Indazol-6-Yl)furo[3,2-D]pyrimidine-2,4-Diamine | IC50 | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurotrophic-tyrosine-kinase-receptor-type-2_8e9db778f4bd5d3fe8d7ccc9e2fca68a.svg) | 4-[6-(3-Fluoro-benzylamino)-imidazo[1,2-b]pyridazin-3-yl]-benzonitrile | IC50 | 21.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurotrophic-tyrosine-kinase-receptor-type-2_f8ee55f6cac6bc1babf9b394bab747fe.svg) | 2-N-(3-Chloro-4-morpholin-4-ylphenyl)-4-N-(2,2,2-trifluoroethyl)furo[3,2-d]pyrimidine-2,4-diamine | IC50 | 8340.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurotrophic-tyrosine-kinase-receptor-type-2_31c978ed7d2f4a459d4126d93c3f2b51.svg) | 5-[(Z)-[6-[3-[[3-(4-Methylpiperazin-1-yl)-5-(trifluoromethyl)benzoyl]amino]anilino]-2-oxo-1H-indol-3-ylidene]methyl]-1H-pyrrole-3-carboxylic acid | IC50 | 17.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurotrophic-tyrosine-kinase-receptor-type-2_69bdb198d3fc14cb93f805297f96e575.svg) | N-[2-(Diethylamino)ethyl]-5-[(Z)-[6-[3-[[3-(4-methylpiperazin-1-yl)-5-(trifluoromethyl)benzoyl]amino]anilino]-2-oxo-1H-indol-3-ylidene]methyl]-1H-pyrrole-3-carboxamide | IC50 | 19.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurotrophic-tyrosine-kinase-receptor-type-2_afa8da84f1cb91bdbfe79048ab9b5517.svg) | 3-(Tert-butylamino)-4-[[2-(4-pyridin-4-ylanilino)pyrimidin-4-yl]amino]cyclobut-3-ene-1,2-dione | Ki | 4500.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurotrophic-tyrosine-kinase-receptor-type-2_4f613ff016a1637c9634d2f135158f01.svg) | (16R)-19-Amino-3-cyclopropyl-13-fluoro-5,8,16-trimethyl-17-oxa-4,5,8,20-tetrazatetracyclo[16.3.1.02,6.010,15]docosa-1(22),2(6),3,10(15),11,13,18,20-octaen-9-one | Ki | 0.4 [1] |
![](https://images.aatbio.com/dataset/ic50/neurotrophic-tyrosine-kinase-receptor-type-2_0cff0442a95cc19f15d685b66b0fdaec.svg) | N-Methyl-7-[3-[4-(piperazin-1-ylmethyl)-3-(trifluoromethyl)phenoxy]prop-1-ynyl]isoquinolin-3-amine | IC50 | 190.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurotrophic-tyrosine-kinase-receptor-type-2_1caad31d3398e28ae5eee611dc232a92.svg) | (20R)-23-Amino-17-fluoro-5,12,20-trimethyl-21-oxa-3,7,9,12,24-pentazapentacyclo[20.3.1.02,10.03,8.014,19]hexacosa-1(26),2(10),4,6,8,14(19),15,17,22,24-decaen-13-one | Ki | 77.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurotrophic-tyrosine-kinase-receptor-type-2_dbe7a4db1e1d17cd0f374ac8f9dd025a.svg) | (20R)-23-Amino-17-fluoro-12,20-dimethyl-13-oxo-21-oxa-3,9,12,24,26-pentazapentacyclo[20.3.1.02,10.03,8.014,19]hexacosa-1(25),2(10),4,6,8,14(19),15,17,22(26),23-decaene-5-carbonitrile | Ki | 65.0 [1] |